Morgan Stanley Issues Positive Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target boosted by Morgan Stanley from $450.00 to $459.00 in a research note released on Tuesday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the pharmaceutical company’s stock. VRTX has been the topic of several other research reports. UBS Group raised their target price […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target boosted by Morgan Stanley from $450.00 to $459.00 in a research note released on Tuesday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the pharmaceutical company’s stock. VRTX has been the topic of several other research reports. UBS Group raised their target price […]
